Copyright
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Exp Med. Jun 20, 2023; 13(3): 7-16
Published online Jun 20, 2023. doi: 10.5493/wjem.v13.i3.7
Published online Jun 20, 2023. doi: 10.5493/wjem.v13.i3.7
Physiopathological mechanisms related to inflammation in obesity and type 2 diabetes mellitus
Ioannis G Lempesis, Vasiliki E Georgakopoulou, Department of Infectious Diseases-COVID-19 Unit, Laiko General Hospital, Athens 11527, Greece
Author contributions: Lempesis IG and Georgakopoulou VE designed research; Lempesis IG and Georgakopoulou VE performed research; Lempesis IG wrote the article; Georgakopoulou VE revised the article.
Conflict-of-interest statement: All the author declare no conflict of interests for this article.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Vasiliki E Georgakopoulou, Doctor, MSc, Doctor, Department of Infectious Diseases-COVID-19 Unit, Laiko General Hospital, 17 Agiou Thoma Street, Athens 11527, Greece. vaso_georgakopoulou@hotmail.com
Received: January 15, 2023
Peer-review started: January 15, 2023
First decision: February 8, 2023
Revised: February 15, 2023
Accepted: April 10, 2023
Article in press: April 10, 2023
Published online: June 20, 2023
Processing time: 152 Days and 7.7 Hours
Peer-review started: January 15, 2023
First decision: February 8, 2023
Revised: February 15, 2023
Accepted: April 10, 2023
Article in press: April 10, 2023
Published online: June 20, 2023
Processing time: 152 Days and 7.7 Hours
Core Tip
Core Tip: A significant amount of literature indicates the relationship between increased inflammatory markers and overweight, obesity, and type 2 diabetes mellitus. Even though the role of inflammation in the development and progression of these conditions is uncertain, the potential use of inflammatory markers as diagnostic and prognostic tools is under vigorous investigation. Weight loss and lifestyle interventions result on reduction of inflammatory markers in individuals with overweight and obesity and/or type 2 diabetes mellitus.